![Søren Nielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Søren Nielsen is the founder of SynAct Pharma AB, which was founded in 2012.
He currently works as a Director at ApoGlyx AB. Previously, he worked as the Chief Executive Officer at Action Pharma A.
Aktiva positioner av Søren Nielsen
| Företag | Position | Start |
|---|---|---|
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Søren Nielsen
| Företag | Position | Slut |
|---|---|---|
| SYNACT PHARMA AB | Grundare | - |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | President | 2010-02-05 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
4
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
